Pour le comité de rédaction de Bibliomed
Société Française de Documentation et de Recherche en Médecine Générale
- Key words: immunological adjuvant, aluminium
- DOI : 10.1684/med.2017.232
- Page(s) : 303-7
- Published in: 2017
Alarming information about the dangers of aluminum (Al) to health is widely reported by the media. They denounce increased risk of dementia and other neurological disorders, but also dangers for bone, hematology, respiratory, immuno-allergy and cancer in situations of overexposure to Al (renal dialysis, work in aluminum factories). If Al, seen as a ubiquitous metal, is a known risk factor for the health of certain populations which are particularly exposed, this is not demonstrated for the general population. There are many alleged risks which remain mainly hypotheses coming out of experimentation, with two dominant but not exclusive controversies about Alzheimer's disease (AD) and vaccinations. The presence of aluminum, in particular as an adjuvant, in a certain number of vaccines is one of the factors that have led to the widespread challenge of vaccinations. This questioning even led to a citizens’ consultation in 2016 which concluded to “the urgent need for a revival of public health policy” in this area and the proposal for a temporary enlargement of vaccine obligations of the child, a measure that is about to be adopted by the authorities against other foreign public health policies. These decisions do not provide a convincing answer to many outstanding issues.
Why should we use adjuvants? Is aluminum a health hazard? Is there a link between vaccines with aluminum adjuvants and the observed symptoms?